Literature DB >> 403135

Cell-mediated resistance to infection with Listeria monocytogenes in nude mice.

P Emmerling, H Finger, H Hof.   

Abstract

Congenitally dysthymic nude (nu/nu) NMRI mice showed increased resistance to viable Listeria monocytogenes cells during the initial phase of infection as compared with euthymic control mice. The intravenous mean lethal dose (LD50), as determined for euthymic mice after an observation time of 7 and 14 days, amounted consistently to 6 X 10(4) Listeria. The corresponding values determined in nude mice were found to be increased by either 20-fold (1.2 X 10(6) Listeria after an observation time of 7 days) or 4-fold (2.4 X 10(5) Listeria after an observation time of 14 days). The transfer of spleen cells from immune euthymic donor mice into chronically infected nude mice caused almost complete elimination of Listeria within 1 week. The injection of dextran sulfate 24 h before a secondary infection with L. monocytogenes caused loss of antibacterial resistance in both chronically infected nude mice and Listeria-immune euthymic mice, this being expressed by a rapid increase in the numbers of bacteria in the spleens as well as the occurrence of serious signs of illness.

Entities:  

Mesh:

Substances:

Year:  1977        PMID: 403135      PMCID: PMC421378          DOI: 10.1128/iai.15.2.382-385.1977

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  15 in total

1.  Activated macrophages in congenitally athymic "nude mice" and in lethally irradiate mice.

Authors:  C Cheers; R Waller
Journal:  J Immunol       Date:  1975-09       Impact factor: 5.422

2.  Requirement for bone marrow-derived cells in resistance to Listeria.

Authors:  P A Campbell; B L Martens; H R Cooper; J K McClatchy
Journal:  J Immunol       Date:  1974-04       Impact factor: 5.422

3.  Early appearance of sensitized lymphocytes in mice infected with Listeria monocytogenes.

Authors:  R M Zinkernagel; R V Blanden; R E Langman
Journal:  J Immunol       Date:  1974-02       Impact factor: 5.422

4.  Effects of bacterial products on lymphocytes and macrophages: their possible role in natural resistance to listeria infetion in mice.

Authors:  J C Petit; E R Unanue
Journal:  J Immunol       Date:  1974-09       Impact factor: 5.422

5.  Listeria monocytogenes infection in nude mice.

Authors:  P Emmerling; H Finger; J Bockemühl
Journal:  Infect Immun       Date:  1975-08       Impact factor: 3.441

6.  Listeria cell wall fraction: a B cell mitogen.

Authors:  J J Cohen; G E Rodriguez; P D Kind; P A Campbell
Journal:  J Immunol       Date:  1975-03       Impact factor: 5.422

7.  The influence of immunologically committed lymphoid cells on macrophage activity in vivo.

Authors:  G B Mackaness
Journal:  J Exp Med       Date:  1969-05-01       Impact factor: 14.307

8.  The production of migration inhibition factor by B and T cells of the guinea pig.

Authors:  T Yoshida; H Sonozaki; S Cohen
Journal:  J Exp Med       Date:  1973-10-01       Impact factor: 14.307

9.  Requirement of thymus (T) lymphocytes for resistance to listeriosis.

Authors:  F C Lane; E R Unanue
Journal:  J Exp Med       Date:  1972-05-01       Impact factor: 14.307

10.  Studies on mediator production by highly purified human T and B lymphocytes.

Authors:  R E Rocklin; R P MacDermott; L Chess; S F Schlossman; J R David
Journal:  J Exp Med       Date:  1974-11-01       Impact factor: 14.307

View more
  32 in total

1.  T-cell-independent macrophage activation in mice induced with rRNA from Listeria monocytogenes and dimethyldioctadecylammonium bromide.

Authors:  J F van den Bosch; I Y Kanis; A C Antonissen; W A Buurman; C P van Boven
Journal:  Infect Immun       Date:  1986-09       Impact factor: 3.441

2.  Role of activated macrophages in resistance of congenitally athymic nude mice to hepatitis induced by herpes simplex virus type 2.

Authors:  S C Mogensen; H K Andersen
Journal:  Infect Immun       Date:  1978-03       Impact factor: 3.441

3.  Experimental pyelonephritis. The effect of T-cell deficiency on the course of hematogenous enterococcal pyelonephritis in the mouse.

Authors:  H Pitchon; R Glassock; G M Kalmanson; L B Guze
Journal:  Am J Pathol       Date:  1984-04       Impact factor: 4.307

4.  Enhancement of host resistance against Listeria infection by Lactobacillus casei: role of macrophages.

Authors:  K Sato
Journal:  Infect Immun       Date:  1984-05       Impact factor: 3.441

5.  Thymosin beta 4: a ubiquitous peptide in rat and mouse tissues.

Authors:  E Hannappel; G J Xu; J Morgan; J Hempstead; B L Horecker
Journal:  Proc Natl Acad Sci U S A       Date:  1982-04       Impact factor: 11.205

6.  CD4+ and CD8+ T-cell-dependent and -independent host defense mechanisms can operate to control and resolve primary and secondary Francisella tularensis LVS infection in mice.

Authors:  J W Conlan; A Sjöstedt; R J North
Journal:  Infect Immun       Date:  1994-12       Impact factor: 3.441

7.  Genetic control of cell-mediated immunity in rats: involvement of RT1.B locus determinants in the proliferative response of T lymphocytes to Listeria antigens.

Authors:  T W Jungi; R Jungi
Journal:  Infect Immun       Date:  1982-11       Impact factor: 3.441

8.  Infectious agents in immunodeficient murine models: pathogenicity of Nocardia asteroides in congenitally athymic (nude) and hereditarily asplenic (Dh/+) mice.

Authors:  B L Beaman; M E Gershwin; S Maslan
Journal:  Infect Immun       Date:  1978-05       Impact factor: 3.441

9.  Efficacy of ampicillin therapy in experimental listeriosis in mice with impaired T-cell-mediated immune response.

Authors:  I A Bakker-Woudenberg; P de Bos; W B van Leeuwen; M F Michel
Journal:  Antimicrob Agents Chemother       Date:  1981-01       Impact factor: 5.191

10.  Two steps in the generation of acquired cellular resistance against Listeria monocytogenes: accumulation and activation of macrophages.

Authors:  M Miyata; M Mitsuyama; N Ogata; K Nomoto; K Takeya
Journal:  Immunology       Date:  1982-10       Impact factor: 7.397

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.